Clinical trials recruiting in Worcester, South Africa
9
Recruiting trials
15
Conditions
Phase breakdown
Phase 2 1Phase 3 8
Conditions recruiting in Worcester, South Africa
Recruiting trials in Worcester, South Africa
- A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
- A Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease (ATTAIN-Outcomes)
- A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
- EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
- Efficacy, Safety and Immunogenicity Evaluation of MTBVAC in Newborns in Sub-Saharan Africa
- Evaluating the Safety and Immunogenicity of MTBVAC
- Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
- Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
- Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
Common questions
How many clinical trials are recruiting in Worcester, South Africa?
9 recruiting trials have at least one study site in Worcester, South Africa.
Is this list complete?
No. For the full record, search ClinicalTrials.gov.